CD83 modulates b cell activation and germinal center responses

Journal of Immunology

Volumn 196, Issue 9, 2016, Pages 3581-3594

  Krzyzak, Lena ^a   Seitz, Christine ^a   Urbat, Anne ^b   Hutzler, Stefan ^b   Ostalecki, Christian ^a   Gläsner, Joachim ^c   Hiergeist, Andreas ^c   Gessner, Andre ^c   Winkler, Thomas H ^d   Steinkasserer, Alexander ^a   Nitschke, Lars ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN E; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CD86 PROTEIN, MOUSE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; BACTERIAL CLEARANCE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GERMINAL CENTER; IN VIVO STUDY; KNOCKOUT MOUSE; LYME DISEASE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; UPREGULATION; ANIMAL; B LYMPHOCYTE; BLOOD; BORRELIA BURGDORFERI; C57BL MOUSE; CYTOLOGY; DEFICIENCY; GENE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; B-LYMPHOCYTES; BORRELIA BURGDORFERI; DENDRITIC CELLS; GENES, MHC CLASS II; GERMINAL CENTER; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; TH2 CELLS;

EID: 84974824387     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502163     Document Type: Article

References (58)

1. Zhou, L. J., R. Schwarting, H. M. Smith, and T. F. Tedder. 1992. A novel cellsurface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149: 735-742.
2. Berchtold, S., P. Muhl-Zurbes, C. Heufler, P. Winklehner, G. Schuler, and A. Steinkasserer. 1999. Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation. FEBS Lett. 461: 211-216.
3. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821-3835.
4. + T cell development in the thymus. Cell 108: 755-767.
5. Wolenski, M., S. O. Cramer, S. Ehrlich, C. Steeg, G. Grossschupff, K. Tenner-Racz, P. Racz, B. Fleischer, and A. von Bonin. 2003. Expression of CD83 in the murine immune system. Med. Microbiol. Immunol. (Berl.) 192: 189-192.
6. + T cells modulates inflammation and autoimmunity. J. Immunol. 180: 5890-5897.
7. Kreiser, S., J. Eckhardt, C. Kuhnt, M. Stein, L. Krzyzak, C. Seitz, C. Tucher, I. Knippertz, C. Becker, C. Gunther, et al. 2015. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology 220: 270-279.
8. Kretschmer, B., K. Luthje, A. H. Guse, S. Ehrlich, F. Koch-Nolte, F. Haag, B. Fleischer, and M. Breloer. 2007. CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells. PLoS One 2: e755.
9. Luthje, K., B. Kretschmer, B. Fleischer, andM. Breloer. 2008. CD83 regulates splenic B cell maturation and peripheral B cell homeostasis. Int. Immunol. 20: 949-960.
10. + T cell longevity in vivo. J. Immunol. 179: 4550-4562.
11. Breloer, M., B. Kretschmer, K. Luthje, S. Ehrlich, U. Ritter, T. Bickert, C. Steeg, S. Fillatreau, K. Hoehlig, V. Lampropoulou, and B. Fleischer. 2007. CD83 is a regulator of murine B cell function in vivo. Eur. J. Immunol. 37: 634-648.
12. Kuwano, Y., C. M. Prazma, N. Yazawa, R. Watanabe, N. Ishiura, A. Kumanogoh, H. Okochi, K. Tamaki, M. Fujimoto, and T. F. Tedder. 2007. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Int. Immunol. 19: 977-992.
13. Kretschmer, B., K. Luthje, S. Schneider, B. Fleischer, and M. Breloer. 2009. Engagement of CD83 on B cells modulates B cell function in vivo. J. Immunol. 182: 2827-2834.
14. Victora, G. D., D. Dominguez-Sola, A. B. Holmes, S. Deroubaix, R. Dalla-Favera, and M. C. Nussenzweig. 2012. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 120: 2240-2248.
15. Victora, G. D., and M. C. Nussenzweig. 2012. Germinal centers. Annu. Rev. Immunol. 30: 429-457.
16. Gatto, D., and R. Brink. 2010. The germinal center reaction. J. Allergy Clin. Immunol. 126: 898-907.
17. McHeyzer-Williams, L. J., P. J. Milpied, S. L. Okitsu, and M. G. McHeyzer-Williams. 2015. Class-switched memory B cells remodel BCRs within secondary germinal centers. Nat. Immunol. 16: 296-305.
18. Tze, L. E., K. Horikawa, H. Domaschenz, D. R. Howard, C. M. Roots, R. J. Rigby, D. A. Way, M. Ohmura-Hoshino, S. Ishido, C. E. Andoniou, et al. 2011. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208: 149-165.
19. Hock, B. D., M. Kato, J. L. McKenzie, and D. N. Hart. 2001. A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int. Immunol. 13: 959-967.
20. Lechmann, M., D. J. Krooshoop, D. Dudziak, E. Kremmer, C. Kuhnt, C. G. Figdor, G. Schuler, and A. Steinkasserer. 2001. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194: 1813-1821.
21. + T cells, and prolongs allogeneic corneal graft survival. J. Immunol. 191: 1965-1975.
22. Eckhardt, J., S. Kreiser, M. Döbbeler, C. Nicolette, M. A. DeBenedette, I. Y. Tcherepanova, C. Ostalecki, A. J. Pommer, C. Becker, C. Gunther, et al. 2014. Soluble CD83 ameliorates experimental colitis in mice. Mucosal Immunol. 7: 1006-1018.
23. Zinser, E., M. Lechmann, A. Golka, M. B. Lutz, and A. Steinkasserer. 2004. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200: 345-351.
24. Hövelmeyer, N., F. T. Wunderlich, R. Massoumi, C. G. Jakobsen, J. Song, M. A. Wörns, C. Merkwirth, A. Kovalenko, M. Aumailley, D. Strand, et al. 2007. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. J. Exp. Med. 204: 2615-2627.
25. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cremediated mutagenesis in mice. Nucleic Acids Res. 25: 1317-1318.
26. Gerlach, J., S. Ghosh, H. Jumaa, M. Reth, J. Wienands, A. C. Chan, and L. Nitschke. 2003. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling. Eur. J. Immunol. 33: 3418-3426.
27. Ehlers, M., H. Fukuyama, T. L. McGaha, A. Aderem, and J. V. Ravetch. 2006. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203: 553-561.
28. Tiller, T., C. E. Busse, and H. Wardemann. 2009. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 350: 183-193.
29. Alamyar, E., P. Duroux, M. P. Lefranc, and V. Giudicelli. 2012. IMGT tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. Methods Mol. Biol. 882: 569-604.
30. Yaari, G., M. Uduman, and S. H. Kleinstein. 2012. Quantifying selection in highthroughput Immunoglobulin sequencing data sets. Nucleic Acids Res. 40: e134.
31. Gläsner, J., H. Blum, V. Wehner, H. U. Stilz, J. D. Humphries, G. P. Curley, A. P. Mould, M. J. Humphries, R. Hallmann, M. Röllinghoff, and A. Gessner. 2005. A small molecule a4b1 antagonist prevents development of murine Lyme arthritis without affecting protective immunity. J. Immunol. 175: 4724-4734.
32. Ackermann, J. A., D. Radtke, A. Maurberger, T. H. Winkler, and L. Nitschke. 2011. Grb2 regulates B-cell maturation, B-cell memory responses and inhibits B-cell Ca2+ signalling. EMBO J. 30: 1621-1633.
33. Hartweger, H., E. Schweighoffer, S. Davidson, M. J. Peirce, A. Wack, and V. L. Tybulewicz. 2014. Themis2 is not required for B cell development, activation, and antibody responses. J. Immunol. 193: 700-707.
34. Arenzana, T. L., M. R. Smith-Raska, and B. Reizis. 2009. Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. Blood 113: 5857-5867.
35. Allen, D., T. Simon, F. Sablitzky, K. Rajewsky, and A. Cumano. 1988. Antibody engineering for the analysis of affinity maturation of an anti-hapten response. EMBO J. 7: 1995-2001.
36. McKisic, M. D., W. L. Redmond, and S. W. Barthold. 2000. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J. Immunol. 164: 6096-6099.
37. Cerutti, A., M. Cols, and I. Puga. 2013. Marginal zone B cells: virtues of innatelike antibody-producing lymphocytes. Nat. Rev. Immunol. 13: 118-132.
38. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
39. Uhde, M., S. Kuehl, U. Richardt, B. Fleischer, and A. Osterloh. 2013. Differential regulation of marginal zone and follicular B cell responses by CD83. Int. Immunol. 25: 507-520.
40. Gitlin, A. D., Z. Shulman, and M. C. Nussenzweig. 2014. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509: 637-640.
41. He, J. S., M. Meyer-Hermann, D. Xiangying, L. Y. Zuan, L. A. Jones, L. Ramakrishna, V. C. de Vries, J. Dolpady, H. Aina, S. Joseph, et al. 2013. The distinctive germinal center phase of IgE+ B lymphocytes limits their contribution to the classical memory response. J. Exp. Med. 210: 2755-2771.
42. Talay, O., D. Yan, H. D. Brightbill, E. E. Straney, M. Zhou, E. Ladi,W. P. Lee, J. G. Egen, C. D. Austin, M. Xu, and L. C. Wu. 2012. IgE+ memory B cells and plasma cells generated through a germinal-center pathway. Nat. Immunol. 13: 396-404.
43. Yang, Z., B. M. Sullivan, and C. D. Allen. 2012. Fluorescent in vivo detection reveals that IgE+ B cells are restrained by an intrinsic cell fate predisposition. Immunity 36: 857-872.
44. Wu, L. C., and A. A. Zarrin. 2014. The production and regulation of IgE by the immune system. Nat. Rev. Immunol. 14: 247-259.
45. McCoy, K. D., N. L. Harris, P. Diener, S. Hatak, B. Odermatt, L. Hangartner, B. M. Senn, B. J.Marsland, M. B. Geuking, H. Hengartner, et al. 2006. Natural IgE production in the absence of MHC class II cognate help. Immunity 24: 329-339.
46. Butt, D., T. D. Chan, K. Bourne, J. R. Hermes, A. Nguyen, A. Statham, L. A. O'Reilly, A. Strasser, S. Price, P. Schofield, et al. 2015. FAS inactivation releases unconventional germinal center B cells that escape antigen control and drive IgE and autoantibody production. Immunity 42: 890-902.
47. Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154: 2866-2877.
48. Erdile, L. F., M. A. Brandt, D. J. Warakomski, G. J. Westrack, A. Sadziene, A. G. Barbour, and J. P. Mays. 1993. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61: 81-90.
49. Keane-Myers, A., and S. P. Nickell. 1995. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 154: 1770-1776.
50. Yin, Z., J. Braun, L. Neure, P.Wu, U. Eggens, A. Krause, T. Kamradt, and J. Sieper. 1997. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 40: 69-79.
51. Yssel, H., M. C. Shanafelt, C. Soderberg, P. V. Schneider, J. Anzola, and G. Peltz. 1991. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 174: 593-601.
52. Akin, E., G. L. McHugh, R. A. Flavell, E. Fikrig, and A. C. Steere. 1999. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67: 173-181.
53. Dressler, F., J. A. Whalen, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167: 392-400.
54. Steere, A. C., and L. Glickstein. 2004. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4: 143-152.
55. Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155: 2020-2028.
56. Matyniak, J. E., and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181: 1251-1254.
57. Malkiel, S., C. J. Kuhlow, P. Mena, and J. L. Benach. 2009. The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease Borrelia. J. Immunol. 182: 498-506.
58. McKisic, M. D., and S. W. Barthold. 2000. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect. Immun. 68: 5190-5197.